|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 38 of 49 found articles
| Title: |
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults |
| Author: |
van der Boor, Saskia C Smit, Merel J van Beek, Stijn W Ramjith, Jordache Teelen, Karina van de Vegte-Bolmer, Marga van Gemert, Geert-Jan Pickkers, Peter Wu, Yimin Locke, Emily Lee, Shwu-Maan Aponte, John King, C Richter Birkett, Ashley J Miura, Kazutoyo Ayorinde, Morolayo A Sauerwein, Robert W ter Heine, Rob Ockenhouse, Christian F Bousema, Teun Jore, Matthijs M McCall, Matthew B B |
| Appeared in: |
The lancet infectious diseases |
| Paging: | Volume 22 () nr. 11 pages 1596-1605 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 38 of 49 found articles
| << previous | next >> |